Finance

Lists
ELIC:STO
Elicera Therapeutics AB
SEK 2,58
-0,58%
(-0,015) 1D
13 Nov., 17:24:15 GMT+1  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ELIC...
Open
SEK 2,60
High
SEK 2,70
Low
SEK 2,54
Mkt. cap
172,51 m
Avg. vol.
208,20 k
Volume
126,65 k
52-wk high
SEK 6,82
52-wk low
SEK 2,24
EPS
-SEK 0,35
Shares outstanding
66,74 m
No. of employees
3
Open
SEK 2,60
High
SEK 2,70
Low
SEK 2,54
Mkt. cap
172,51 m
Avg. vol.
208,20 k
Volume
126,65 k
52-wk high
SEK 6,82
52-wk low
SEK 2,24
EPS
-SEK 0,35
Shares outstanding
66,74 m
No. of employees
3
News stories
From web sources and news partners
About Elicera Therapeutics AB
CEO-
Employees3
Founded2014
Headquarters-
SectorHealth Care
Industry-
Websiteelicera.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,91 m
30,00 k
-
-147,66 k
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,76 m
7,16 m
5,12 m
6,16 m
Operating expense
7,76 m
7,16 m
5,12 m
6,16 m
Total operating expenses
7,76 m
7,16 m
5,12 m
6,16 m
Operating income
146,69 k
-7,13 m
-5,12 m
-6,31 m
Other non operating income
1,32 k
-
-
-4,00 k
EBT including unusual items
304,15 k
-6,97 m
-5,06 m
-6,26 m
EBT excluding unusual items
304,15 k
-6,97 m
-5,06 m
-6,26 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
304,15 k
-6,97 m
-5,06 m
-6,26 m
Net profit margin
3,85%
-23 219,94%
-
4 240,78%
Earnings per share
-
-
-
-
Interest and investment income
156,14 k
169,41 k
61,50 k
47,75 k
Interest expense
-
-5,07 k
-4,78 k
-45,00
Net interest expenses
156,14 k
164,34 k
56,72 k
47,71 k
Depreciation and amortization charges
-
-
-
-
EBITDA
149,63 k
-7,13 m
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme